[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@Mike182035 Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1649320141505609729.png) @Mike182035 Mike Wilk

Mike Wilk posts on X about novartis, $bns, finance, settings the most. They currently have XX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::1649320141505609729/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1649320141505609729/c:line/m:interactions.svg)

- X Week XXXXX -XXXX%
- X Month XXXXXX +987%
- X Months XXXXXX -XX%
- X Year XXXXXXX +421%

### Mentions: X [#](/creator/twitter::1649320141505609729/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1649320141505609729/c:line/m:posts_active.svg)

- X Week XX -XXXX%
- X Month XX +900%
- X Months XX -XX%
- X Year XXX +600%

### Followers: XX [#](/creator/twitter::1649320141505609729/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1649320141505609729/c:line/m:followers.svg)

- X Week XX +7.90%
- X Month XX +12%
- X Months XX +20%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::1649320141505609729/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1649320141505609729/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1649320141505609729/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXXX% [finance](/list/finance)  XXXXX%

**Social topic influence**
[novartis](/topic/novartis) #38, [$bns](/topic/$bns) 6.25%, [finance](/topic/finance) 6.25%, [settings](/topic/settings) XXXX%

**Top accounts mentioned or mentioned by**
[@tragedycalls](/creator/undefined) [@tomthebomb](/creator/undefined) [@seandentbsc](/creator/undefined) [@jimbalim69](/creator/undefined) [@bramosh7](/creator/undefined) [@towlie1981](/creator/undefined) [@experiencesvip](/creator/undefined) [@char101091](/creator/undefined) [@fizzy864729](/creator/undefined) [@ducatistealth](/creator/undefined) [@paulsemple9](/creator/undefined) [@jenkoool](/creator/undefined)

**Top assets mentioned**
[Novartis AG (NVS)](/topic/novartis) [Bank of Nova Scotia (BNS)](/topic/$bns)
### Top Social Posts [#](/creator/twitter::1649320141505609729/posts)
---
Top posts by engagements in the last XX hours

"#AVCT There is very little doubt that all relevant Pharma are aware of Avacta - it's just a non topic She's an ex Avacta employee I believe"  
[X Link](https://x.com/Mike182035/status/1980975279993389523) [@Mike182035](/creator/x/Mike182035) 2025-10-22T12:31Z XX followers, 2202 engagements


"#AVCT Don't you mean $bns question Ben It's a guess but I have a suspicion this development will shortly be shown to be funded"  
[X Link](https://x.com/Mike182035/status/1977702794661412914) [@Mike182035](/creator/x/Mike182035) 2025-10-13T11:47Z XX followers, 1255 engagements


"#AVCT This is actually also part of the arguement for BP to partner rather than early takeover The former a cheaper method of backing both horses"  
[X Link](https://x.com/Mike182035/status/1980905318562574547) [@Mike182035](/creator/x/Mike182035) 2025-10-22T07:53Z XX followers, 1411 engagements


"#AVCT Not allowed to reply Jason But tbh I think practically all serious pharma are contenders And I am being serious too"  
[X Link](https://x.com/Mike182035/status/1980967079055409193) [@Mike182035](/creator/x/Mike182035) 2025-10-22T11:58Z XX followers, 2920 engagements


"@Bramosh7 #AVCT I'm a bull too and those ball park numbers imo are where we could ultimately go over several years. My main interest playing with grok is gameing scenarios how to finance getting there. Latest theory is using mid cap partnerships as in reality BP seem cool to #onourterms"  
[X Link](https://x.com/Mike182035/status/1982395617730277828) [@Mike182035](/creator/x/Mike182035) 2025-10-26T10:35Z XX followers, XX engagements


"#AVCT 2/n "4. Illustrative ExampleImagine AVA6207 in pancreatic cancer (KRAS-driven mito-addicted):Primary Warhead: Exatecan (topo I inhibitor) causes DNA breaks killing proliferative cells. Mito-Warhead: Venetoclax (BCL-2 inhibitor) hits mitochond.""  
[X Link](https://x.com/Mike182035/status/1981429999996482036) [@Mike182035](/creator/x/Mike182035) 2025-10-23T18:38Z XX followers, XXX engagements


"#AVCT 3/n ".mitochondria releasing cytochrome c and collapsing m. This:Sensitizes: Lowers apoptosis threshold so exatecans DNA damage triggers faster cell death. Blocks Resistance: Prevents OXPHOS/BCL-2 upregulation in hypoxic stem cells which would otherwise." ""  
[X Link](https://x.com/Mike182035/status/1981431236120985968) [@Mike182035](/creator/x/Mike182035) 2025-10-23T18:43Z XX followers, XXX engagements


"#AVCT ".Verdict: The triple-warhead construct is the stronger contender for CSC-driven TNBC leveraging mito-specificity to tackle relapse (40-50% vs. XX% CSC kill) but its longer timeline (9-11 vs. 8-9 years) and tox risks make the dual-warhead a safer faster bet for .""  
[X Link](https://x.com/Mike182035/status/1981450579667792226) [@Mike182035](/creator/x/Mike182035) 2025-10-23T20:00Z XX followers, XXX engagements


"#AVCT ".market entry. Triples edge shines in refractory settings aligning with Avactas 2025 vision (AVA6207s CSC focus) and . mito-expertise. Monitor Avactas October XX 2025 investor update for triple-warhead hints." Usual AI caveats - garbage in garbage out"  
[X Link](https://x.com/Mike182035/status/1981451208914035112) [@Mike182035](/creator/x/Mike182035) 2025-10-23T20:02Z XX followers, 1005 engagements